World Continuous Glucose Monitoring Systems Market Worth USD 2,930 Billion by 2021 - Analysis, Opportunities, Trends & Forecasts 2015-2021

Dec 07, 2015, 03:15 ET from Research and Markets

DUBLIN, December 7, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/s6jqqj/world_continuous) has announced the addition of the "World Continuous Glucose Monitoring Systems - Market Opportunities and Forecasts, 2014 - 2021" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

According to a new report titled, "World Continuous Glucose Monitoring (CGM) Systems - Market Opportunities and Forecasts, 2014 -2021", the global continuous glucose monitoring market would generate a revenue of $2,930 million by 2021, registering a CAGR of 31.3% during 2015-2021. CGM sensors accounted for about two-third share of the global CGM components market in 2014 and would continue to dominate the market until 2021. 

The need of active management and control of diabetes has grown considerably with growing number of diabetic population and associated cost burden. It is projected that, by 2035, the diabetes-affected patient population would reach 471 million with an associated cost burden of $627 billion. Continuous monitoring and managing glucose levels is an essential factor in diabetes management, which is primarily delivered by CGMs. In the progression, many high-tech variants of CGMs have evolved such as smartphone-connected CGMs, wearable CGMs and non-invasive CGMs. 

The improved efficacy and high disease prevalence has brought these devices to center stage to glucose monitoring. Increasing awareness, FDA approval to the novel and innovative products such as bionic pancreas and focus on developing CGM devices to serve new end user segment are prime drivers to the growth of CGM market. However, lack of adequate reimbursement regime for devices and clinicians, has been the key barrier to the adoption of the devices. Sensors led the market for CGM components and would also be the fastest growing segment. This growth is primarily supplemented by the recurring sales, high frequency of use, bulk purchasing and the limited life of sensors. Integrated insulin pumps would emerge as the lucrative market segment over the forecast period. 

Companies Mentioned:  

  • Abbott
  • Animas
  • Dexcom
  • Glysens
  • Insulet
  • Medtronic
  • Omnipod
  • Roche
  • Senseonics
  • Yposomed

Report Structure:

Chapter: 1 INTRODUCTION 

Chapter: 2 EXECUTIVE SUMMARY 

Chapter: 3 MARKET OVERVIEW 

Chapter: 4 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET- BY COMPONENTS 

Chapter: 5 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER SEGMENT 

Chapter: 6 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET Â BY AGE DEMOGRAPHICS 

Chapter: 7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET- BY GEOGRAPHY 

Chapter: 8 COMPANY PROFILES 

For more information visit http://www.researchandmarkets.com/research/s6jqqj/world_continuous

About Research and Markets 

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Laura Wood
+353-1-481-1716
press@researchandmarkets.net


SOURCE Research and Markets